$AXDX

Accelerate Diagnostics Inc

  • NASDAQ
  • Health Technology
  • Biotechnology
  • Medical Specialties
  • Manufacturing
  • Analytical Laboratory Instrument Manufacturing

PRICE

$1.04 ▲4.765%

Last Close

VOLUME

497,715

DAY RANGE

0.9342 - 1.08

52 WEEK

0.502 - 8.05

Join Discuss about AXDX with like-minded investors

profile
@HeyShoe #droscrew
recently

RECAP 11/30 Chatter: $RAD + Chatter (DR) $BIIB - Loses Tecfidera patent ruling $ZEN + Jana wants $MNTV deal killed $AXDX + $5M Insider Buy $LGVN + Japan Lomecel-B

116 Replies 15 👍 9 🔥

profile
@CarlosH-carvan #ivtrades
recently

$AXDX squeeze watch

121 Replies 14 👍 14 🔥

profile
@CarlosH-carvan #ivtrades
recently

$PRTS, $GSX, $OTRK, $CLVS, $GOGO, $TR, $AXDX, $SKT, $SPWR,

144 Replies 15 👍 12 🔥

Key Metrics

Market Cap

72.45 M

Beta

1.31

Avg. Volume

2.15 M

Shares Outstanding

69.66 M

Yield

0%

Public Float

0

Next Earnings Date

2022-08-04

Next Dividend Date

Company Information

Accelerate Diagnostics, Inc. is an in vitro diagnostics company dedicated to providing solutions for the global challenges of antibiotic resistance and sepsis. The Accelerate Pheno® system and Accelerate PhenoTest® BC kit combine several technologies aimed at reducing the time clinicians must wait to determine the most optimal antibiotic therapy for deadly infections. The FDA cleared system and kit fully automate the sample preparation steps to report phenotypic antibiotic susceptibility results in approximately 7 hours direct from positive blood cultures. Recent external studies indicate the solution offers results 1-2 days faster than existing methods, enabling clinicians to optimize antibiotic selection and dosage specific to the individual patient days earlier.

CEO: John Phillips

Website:

HQ: 3950 S Country Club Rd Ste 470 Bldg 3-307 Tucson, 85714-2240 Arizona

Related News